Kunpeng Lv

NHC Key Laboratory Of Glycoconjugate Research
Shanghai, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Targeting myeloid checkpoint Siglec-10 reactivates antitumor immunity and improves anti-programmed cell death 1 efficacy in gastric cancer.

Targeting myeloid checkpoint Siglec-10 reactivates antitumor immunity and improves anti-programmed cell death 1 efficacy in gastric cancer.

Journal: Journal for immunotherapy of cancer

Published: October 17, 2023

C-type lectin receptor Dectin-1 blockade on tumour-associated macrophages improves anti-PD-1 efficacy in gastric cancer.

C-type lectin receptor Dectin-1 blockade on tumour-associated macrophages improves anti-PD-1 efficacy in gastric cancer.

Journal: British journal of cancer

Published: November 21, 2022

Complement receptor C5aR1 blockade reprograms tumor-associated macrophages and synergizes with anti-PD-1 therapy in gastric cancer.

Complement receptor C5aR1 blockade reprograms tumor-associated macrophages and synergizes with anti-PD-1 therapy in gastric cancer.

Journal: International journal of cancer

Published: November 03, 2022

TIM3+ cells in gastric cancer: clinical correlates and association with immune context.

TIM3+ cells in gastric cancer: clinical correlates and association with immune context.

Journal: British journal of cancer

Published: September 08, 2021

Impact of intratumoural CD73 expression on prognosis and therapeutic response in patients with gastric cancer.

Impact of intratumoural CD73 expression on prognosis and therapeutic response in patients with gastric cancer.

Journal: European journal of cancer (Oxford, England : 1990)

Published: May 22, 2021

Poor clinical outcomes and immunoevasive contexture in CXCL13+CD8+ T cells enriched gastric cancer patients.

Poor clinical outcomes and immunoevasive contexture in CXCL13+CD8+ T cells enriched gastric cancer patients.

Journal: Oncoimmunology

Published: May 17, 2021

ASO Author Reflections: Optimization of Tumor Therapy for the Specific Immune Microenvironment of Gastric Cancer.

ASO Author Reflections: Optimization of Tumor Therapy for the Specific Immune Microenvironment of Gastric Cancer.

Journal: Annals of surgical oncology

Published: March 10, 2021

Intratumoral interleukin-9 delineates a distinct immunogenic class of gastric cancer patients with better prognosis and adjuvant chemotherapeutic response.

Intratumoral interleukin-9 delineates a distinct immunogenic class of gastric cancer patients with better prognosis and adjuvant chemotherapeutic response.

Journal: Oncoimmunology

Published: December 23, 2020

Intratumoral CD103+CD4+ T cell infiltration defines immunoevasive contexture and poor clinical outcomes in gastric cancer patients.

Intratumoral CD103+CD4+ T cell infiltration defines immunoevasive contexture and poor clinical outcomes in gastric cancer patients.

Journal: Oncoimmunology

Published: December 14, 2020

Tumor-infiltrating podoplanin+ cells in gastric cancer: clinical outcomes and association with immune contexture.

Tumor-infiltrating podoplanin+ cells in gastric cancer: clinical outcomes and association with immune contexture.

Journal: Oncoimmunology

Published: November 25, 2020

Intratumoral Foxp3+RORγt+ T cell infiltration determines poor prognosis and immunoevasive contexture in gastric cancer patients.

Intratumoral Foxp3+RORγt+ T cell infiltration determines poor prognosis and immunoevasive contexture in gastric cancer patients.

Journal: Cancer immunology, immunotherapy : CII

Published: November 09, 2020

Manipulation of focal Wnt activity via synthetic cells in a double-humanized zebrafish model of tumorigenesis.

Manipulation of focal Wnt activity via synthetic cells in a double-humanized zebrafish model of tumorigenesis.

Journal: International journal of cancer

Published: October 30, 2020

Showing 1-12 of 23

Last Updated: 09/26/2026